Rapid Dose Therapeutics (XCNQ:DOSE) Asset Impairment Charge : C$0.00 Mil (TTM As of Nov. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics Asset Impairment Charge?

Rapid Dose Therapeutics's Asset Impairment Charge for the three months ended in Nov. 2024 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Nov. 2024 was C$0.00 Mil.

Rapid Dose Therapeutics Asset Impairment Charge Historical Data

The historical data trend for Rapid Dose Therapeutics's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Asset Impairment Charge Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Asset Impairment Charge

Get a 7-Day Free Trial

4.09

Rapid Dose Therapeutics Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Rapid Dose Therapeutics Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Rapid Dose Therapeutics Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

RDTCF:USA

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Executives

Mark Upsdell	Director
Brian Howlett	Director

Rapid Dose Therapeutics Headlines

No Headlines